Your browser doesn't support javascript.
loading
Optimal treatment for Philadelphia-negative acute lymphoblastic leukemia in first remission in the era of high-intensity chemotherapy.
Kako, Shinichi; Hayakawa, Fumihiko; Imai, Kiyotoshi; Tanaka, Junji; Mizuta, Shuichi; Nishiwaki, Satoshi; Kanamori, Heiwa; Mukae, Junichi; Ozawa, Yukiyasu; Kondo, Tadakazu; Fukuda, Takahiro; Ichinohe, Tatsuo; Ota, Shuichi; Tanaka, Yoshinori; Murayama, Tohru; Kurahashi, Shingo; Sakura, Toru; Usui, Noriko; Ohtake, Shigeki; Kiyoi, Hitoshi; Matsumura, Itaru; Miyazaki, Yasushi; Atsuta, Yoshiko.
Affiliation
  • Kako S; Division of Hematology, Department of Internal Medicine, Jichi Medical University Saitama Medical Center, 1-847 Amanuma, Omiya-ku, Saitama, Saitama, 330-8503, Japan. shinichikako@asahi-net.email.ne.jp.
  • Hayakawa F; Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Imai K; Department of Hematology, Otaru General Hospital, Otaru, Japan.
  • Tanaka J; Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan.
  • Mizuta S; Department of Immunology and Hematology, Kanazawa Medical University, Ishikawa, Japan.
  • Nishiwaki S; Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
  • Kanamori H; Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan.
  • Mukae J; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Ozawa Y; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
  • Kondo T; Department of Hematology, Kyoto University Hospital, Kyoto, Japan.
  • Fukuda T; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
  • Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Ota S; Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan.
  • Tanaka Y; Third Department of Internal Medicine, Yamaguchi University School of Medicine, Yamaguchi, Japan.
  • Murayama T; Department of Hematology, Hyogo Cancer Center, Akashi, Japan.
  • Kurahashi S; Division of Hematology and Oncology, Toyohashi Municipal Hospital, Aichi, Japan.
  • Sakura T; Leukemia Research Center, Saiseikai Maebashi Hospital, Maebashi, Japan.
  • Usui N; Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
  • Ohtake S; Kanazawa University, Kanazawa, Japan.
  • Kiyoi H; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Matsumura I; Department of Hematology/Rheumatology, Faculty of Medicine, Kindai University, Osakasayama, Japan.
  • Miyazaki Y; Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
  • Atsuta Y; Department of Healthcare Administration, Nagoya University, Nagoya, Japan.
Int J Hematol ; 114(5): 608-619, 2021 Nov.
Article de En | MEDLINE | ID: mdl-34328634
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protocoles de polychimiothérapie antinéoplasique / Leucémie-lymphome lymphoblastique à précurseurs B et T Type d'étude: Diagnostic_studies / Etiology_studies / Prognostic_studies Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Int J Hematol Sujet du journal: HEMATOLOGIA Année: 2021 Type de document: Article Pays d'affiliation: Japon
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protocoles de polychimiothérapie antinéoplasique / Leucémie-lymphome lymphoblastique à précurseurs B et T Type d'étude: Diagnostic_studies / Etiology_studies / Prognostic_studies Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Int J Hematol Sujet du journal: HEMATOLOGIA Année: 2021 Type de document: Article Pays d'affiliation: Japon